Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
These may have ingredients like berberine, cinnamon, garcinia, etc., which claim to help manage appetite, reduce insulin resistance, manage blood sugar levels and support overall wellness 9 , 10 , 12
In addition, despite continuous discussions about affordability, insurers are progressively expanding reimbursement coverage, increasing the accessibility of these treatments
Potential candidates for semaglutide treatment may include individuals with the following conditions: It is important to keep in mind that this medication is not for everyone